📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
China National Medicines Corp Ltd
China National Medicines's GHG Emissions Data Preview
In 2024, China National Medicines completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, China National Medicines has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind China National Medicines’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore China National Medicines’s data sources below and access millions more through our Disclosure Search.
Insights into China National Medicines's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofChina National Medicines amounted to25,825metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
China National Medicines's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are China National Medicines's Scope 1 emissions?
In 2024, the total Scope 1 emissions of China National Medicines were 907 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
What are China National Medicines's Scope 2 emissions?
In 2024, China National Medicines reported Scope 2 greenhouse gas (GHG) emissions of 24,918 tCOâ‚‚e without specifying the calculation method.a
What methodology does China National Medicines use for Scope 2 reporting?
In 2024, China National Medicines reported its Scope 2 emissions using an unspecified methodology.a
China National Medicines's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into China National Medicines’s GHG Emissions Intensity Compared to Industry Peers
In 2024, China National Medicines reported Scope 1 greenhouse gas (GHG) emissions of 907 tCOâ‚‚e and total revenues of USD 6,934 millions. This translates into an emissions intensity of 0.13 tCOâ‚‚e per millions USD.a
China National Medicines's Scope 1 Emissions Intensity Compared to Peers
How does China National Medicines's GHG emissions intensity compare to its peers?
In 2024, China National Medicines reported a Scope 1 emissions intensity of 0.13 tCOâ‚‚e per millions USD. Compared to the peer group median of 5.6, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does China National Medicines rank on GHG emissions intensity within its industry?
In 2024, China National Medicines ranked 2 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places China National Medicines among the top performers, with one of the lowest emissions intensities relative to peers.a